Venture Capital News and Headlines
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Venture CapitalNewsKailera Therapeutics Inks $600 Million Series B
Kailera Therapeutics Inks $600 Million Series B
Venture Capital

Kailera Therapeutics Inks $600 Million Series B

•November 8, 2025
0
VC News Daily
VC News Daily•Nov 8, 2025

Why It Matters

The large raise signals strong market confidence in obesity treatments and equips Kailera to advance a potentially market‑changing weight‑loss drug through late‑stage trials, positioning it for a significant commercial opportunity.

Kailera Therapeutics Inks $600 Million Series B

Read Original Article
0

Comments

Want to join the conversation?

Loading comments...